S&P 500

5.222,68

0,16%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Antares Pharma Inc (ATRS)
Antares Pharma Inc (ATRS) Notícias

ATRS

Antares Pharma (ATRS)

Antares Pharma Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:ATRS

1 2 3 4 5 6 7 8 9 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
26/05/2022	18:31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ATRS	Antares Pharma Inc
24/05/2022	17:50	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ATRS	Antares Pharma Inc
24/05/2022	17:32	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ATRS	Antares Pharma Inc
24/05/2022	17:23	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ATRS	Antares Pharma Inc
24/05/2022	10:08	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:ATRS	Antares Pharma Inc
24/05/2022	07:11	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:ATRS	Antares Pharma Inc
13/05/2022	17:46	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:ATRS	Antares Pharma Inc
12/05/2022	09:00	PR Newswire (US)	Hart-Scott-Rodino Waiting Period Expires for Halozyme's Acquisition of Antares Pharma	NASDAQ:ATRS	Antares Pharma Inc
10/05/2022	18:28	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ATRS	Antares Pharma Inc
06/05/2022	13:10	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ATRS	Antares Pharma Inc
02/05/2022	17:50	Business Wire	ANTARES PHARMA INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Antares Pharma, Inc. - ATRS	NASDAQ:ATRS	Antares Pharma Inc
02/05/2022	07:03	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ATRS	Antares Pharma Inc
29/04/2022	18:56	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:ATRS	Antares Pharma Inc
26/04/2022	08:17	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:ATRS	Antares Pharma Inc
26/04/2022	08:02	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:ATRS	Antares Pharma Inc
14/04/2022	07:10	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:ATRS	Antares Pharma Inc
13/04/2022	07:00	PR Newswire (US)	Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader	NASDAQ:ATRS	Antares Pharma Inc
29/03/2022	08:00	GlobeNewswire Inc.	Antares Pharma Announces FDA Approval Of TLANDO™, an Oral Treatment for Testosterone Replacement Therapy	NASDAQ:ATRS	Antares Pharma Inc
07/03/2022	08:16	TipRanks	Analysts Are Bullish on Top Healthcare Stocks: Aclaris Therapeutics (ACRS), Antares Pharma (ATRS)	NASDAQ:ATRS	Antares Pharma Inc
03/03/2022	09:00	GlobeNewswire Inc.	Antares Pharma Reports Fourth Quarter and Full-Year 2021 Financial and Operating Results	NASDAQ:ATRS	Antares Pharma Inc
28/02/2022	10:30	GlobeNewswire Inc.	Antares Pharma to Present at the Cowen 42nd Annual Healthcare Conference	NASDAQ:ATRS	Antares Pharma Inc
17/02/2022	10:30	GlobeNewswire Inc.	Antares Pharma To Report Fourth Quarter And Full-Year 2021 Financial And Operating Results	NASDAQ:ATRS	Antares Pharma Inc
03/02/2022	10:00	GlobeNewswire Inc.	Antares Pharma Announces FDA Acceptance of NDA Resubmission for TLANDO®	NASDAQ:ATRS	Antares Pharma Inc
01/02/2022	19:16	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ATRS	Antares Pharma Inc
18/01/2022	09:30	GlobeNewswire Inc.	Antares Pharma Receives FDA Fast Track Designation for ATRS-1902 for Adrenal Crisis Rescue	NASDAQ:ATRS	Antares Pharma Inc
12/01/2022	11:06	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:ATRS	Antares Pharma Inc
12/01/2022	10:30	GlobeNewswire Inc.	Antares Pharma Appoints Claude E. Richardson as Senior Vice President of Human Resources	NASDAQ:ATRS	Antares Pharma Inc
11/01/2022	09:30	GlobeNewswire Inc.	Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue	NASDAQ:ATRS	Antares Pharma Inc
17/12/2021	09:53	GlobeNewswire Inc.	MedMira strengthen its Board with New Appointment	NASDAQ:ATRS	Antares Pharma Inc
15/12/2021	19:58	GlobeNewswire Inc.	Antares Pharma Announces Divestiture of Otrexup®	NASDAQ:ATRS	Antares Pharma Inc